For 120 Years, We Assumed Alzheimer's Was Forever. This Study Reversed It.

Researchers at Case Western Reserve University just reversed advanced Alzheimer's disease in mice. Not slowed it. Reversed it. Complete cognitive recovery in animals with severe brain damage.

The breakthrough challenges 120 years of assumptions about what's possible.

What They Found

The study, published December 22 in Cell Reports Medicine, identified a critical failure at the center of Alzheimer's: the brain can't maintain healthy levels of NAD+, a cellular energy molecule.

When NAD+ drops too low, brain cells starve. Plaques form. Memory disappears.

The researchers did two things. First, they maintained normal NAD+ levels before symptoms appeared. The mice never developed Alzheimer's.

Second — and this is what changed everything — they restored NAD+ balance after the disease was already advanced.

The brain repaired itself. Cognitive function came back. Completely.

Two Models, Same Result

They tested this in two different mouse models carrying different genetic mutations known to cause Alzheimer's in humans. One involved amyloid processing. The other involved tau protein.

Both models showed widespread brain damage: broken blood-brain barrier, nerve fiber destruction, chronic inflammation, weakened connections between cells, severe memory problems.

Both models recovered fully when NAD+ balance was restored.

Dr. Andrew Pieper, senior author and Director of the Brain Health Medicines Center at University Hospitals: "Restoring the brain's energy balance achieved pathological and functional recovery in both lines of mice with advanced Alzheimer's. Seeing this effect in two very different animal models, each driven by different genetic causes, strengthens the idea that restoring the brain's NAD+ balance might help patients recover from Alzheimer's."

The Century We Spent on the Wrong Target

For more than 100 years, Alzheimer's research focused on amyloid plaques and tau tangles. Drug companies poured billions into clearing them.

Every drug failed.

What if plaques aren't the cause? What if they're the symptom?

The Case Western study suggests plaques form because neurons lose their energy supply. Mitochondria — the cellular power plants — fail. Cells starve. Plaques accumulate.

Fix the energy problem, and the plaques clear on their own.

According to research published in Nature's Molecular Neurodegeneration journal, mounting evidence shows mitochondrial dysfunction plays a fundamental role in Alzheimer's pathogenesis. The energy failure likely comes first. The plaques follow.

What's Different About This Approach

The researchers used a compound called P7C3-A20, developed in the Pieper laboratory, to restore NAD+ balance.

This isn't the same as over-the-counter NAD+ supplements. Dr. Pieper cautioned that supplements can push NAD+ to dangerously high levels linked to cancer in animal studies.

P7C3-A20 doesn't flood the system. It helps cells maintain healthy NAD+ balance during extreme stress, keeping levels in their normal range.

The technology is being commercialized by Glengary Brain Health, a Cleveland-based company co-founded by Dr. Pieper.

The Shift That Matters

Dr. Pieper: "The key takeaway is a message of hope -- the effects of Alzheimer's disease may not be inevitably permanent. The damaged brain can, under some conditions, repair itself and regain function."

No Alzheimer's drug trial has ever been designed with the goal of reversing the disease and recovering cognitive abilities. Every trial aimed at prevention or slowing progression.

This study asked a different question: can brains already damaged by advanced Alzheimer's recover?

The answer in mice: yes.

What Comes Next

The results need to translate to humans. That's not guaranteed. Many treatments that work in mice fail in people.

But the findings open a path.

Dr. Kalyani Chaubey, lead researcher: "Through our study, we demonstrated one drug-based way to accomplish this in animal models, and also identified candidate proteins in the human AD brain that may relate to the ability to reverse AD."

Next steps include human clinical trials, pinpointing which aspects of brain energy balance matter most for recovery, and testing whether this approach works for other age-related neurodegenerative diseases.

What This Means

If cellular energy failure drives Alzheimer's, then decades of research targeting plaques missed the root cause.

Billions spent. Hundreds of failed trials. Millions of patients told nothing could be done.

Meanwhile, the real problem might have been sitting in the mitochondria the whole time.

This doesn't mean the answer is here yet. It means the question changed.

And changing the question might be what finally gets us an answer.

---

Frequently Asked Questions

Is this proven to work in humans?

Not yet. The study showed full reversal in two different mouse models. Human trials are the next step. Many treatments that work in mice don't translate to people, but the results are encouraging enough to warrant testing.

What's NAD+ and why does it matter?

NAD+ is a molecule that cells need to produce energy. It naturally declines with age throughout the body, including the brain. When it drops too low, cells can't carry out essential functions. The researchers found this decline is far more severe in Alzheimer's brains.

How is this different from past Alzheimer's drugs?

Past drugs targeted amyloid plaques and tau tangles, trying to clear them. This approach restores the brain's energy balance, which appears to let the brain clear plaques on its own. It treats a potential cause rather than symptoms.

When might this become available?

Unknown. Human clinical trials haven't started yet. Even if trials begin soon, developing and approving a treatment takes years. The technology is being commercialized by Glengary Brain Health.

Should people take NAD+ supplements?

The researchers specifically warned against this. Over-the-counter NAD+ supplements can raise levels too high, which has been linked to cancer in animal studies. The compound used in this study (P7C3-A20) works differently — it helps maintain healthy balance without overshooting.